PFS serves as a valuable metric for assessing the effectiveness of a treatment. Unlike overall survival (OS), which measures the time from diagnosis or treatment start until death, PFS focuses on the period where the disease remains stable. This can be particularly important for patients with advanced cancer or those undergoing targeted therapies and immunotherapies.
